CDDO-EA
CAS No. 932730-51-3
CDDO-EA ( CDDO ethyl amide | TP319 | RTA 405 )
产品货号. M26099 CAS No. 932730-51-3
CDDO-EA 是 Nrf2/抗氧化反应元件的激活剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1644 | 有现货 |
|
| 10MG | ¥2993 | 有现货 |
|
| 25MG | ¥4622 | 有现货 |
|
| 50MG | ¥6501 | 有现货 |
|
| 100MG | ¥8478 | 有现货 |
|
| 200MG | ¥11430 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1891 | 有现货 |
|
生物学信息
-
产品名称CDDO-EA
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CDDO-EA 是 Nrf2/抗氧化反应元件的激活剂。
-
产品描述CDDO-EA is an activator of the Nrf2/antioxidant response element.(In Vitro):In a cell culture model of ALS, CDDO-EA potently activates Nrf2/ARE . CDDO-EA induces apoptosis in A549 lung cancer cells and induces heme oxygenase-1. CDDO-EA is 7-fold more potent than CDDO as a suppressor of the ability of IFN-γ to induce iNOS in RAW264.7 macrophage-like cells.(In Vivo):CDDO-EA-treated G93A mice live significantly longer than the control. CDDO-EA increases the life-span from 124.05 days to 144.72 days (16.6%). In CDDO-EA-treated G93A mice, the age of death is 141.4 days and the duration from the age of onset to the age of death is 57.6 days. The age of death from the onset is prolonged by 17.5 days (43%) .
-
体外实验CDDO-EA potently activates Nrf2/ARE in a cell culture model of ALS and in the G93A SOD1 mouse model of ALS. CDDO-EA is a potent inducer of apoptosis in A549 lung cancer cells, as shown both by PARP cleavage and Annexin staining. CDDO-EA is more potent than CDDO itself as inducers of heme oxygenase-1 (HO-1). In RAW264.7 macrophage-like cells, CDDO-EA is 7-fold more potent than CDDO as suppressors of the ability of IFN-γ to induce iNOS.
-
体内实验The survival analysis shows that G93A mice treated with CDDO-EA, compared to G93A littermate controls, lives significantly longer. CDDO-EA treatment increases the life-span by 20.6 days from 124.05±3.7 days to 144.72±8.1 days (16.6%) (p<0.001). In CDDO-EA-treated G93A mice, the age of death is 141.4±5.2 days and the duration from the age of onset to the age of death is 57.6±7.6 days, which means that the age of death from onset is prolonged by 17.5 days (43%).
-
同义词CDDO ethyl amide | TP319 | RTA 405
-
通路Nuclear Receptor/Transcription Factor
-
靶点Keap1-Nrf2
-
受体E3 Ligase Ligand-Linker Conjugate
-
研究领域——
-
适应症——
化学信息
-
CAS Number932730-51-3
-
分子量518.73
-
分子式C33H46N2O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 16.67 mg/mL (32.14 mM)
-
SMILESC(NCC)(=O)[C@]12[C@]([C@@]3([C@@](C)(CC1)[C@@]4(C)C(=CC3=O)[C@]5(C)[C@@](CC4)(C(C)(C)C(=O)C(C#N)=C5)[H])[H])(CC(C)(C)CC2)[H]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Guangrong Zheng, et al. Compounds that induce degradation of anti-apoptotic bcl-2 family proteins and the uses thereof. WO2017184995A1.
产品手册
关联产品
-
Khasianine
Khasianine 对 CCl4 引起的肝损伤具有很强的活性。
-
K67
K67 特异性抑制 Keap1 和 S349磷酸化 p62 之间的相互作用。K67 抑制 p-p62 与 Keap1 的竞争性结合,通过恢复 Keap1 驱动的 Nrf2 泛素化降解,有效抑制高表达S351磷酸化 p62 的 HCC 细胞的增殖。
-
Tigloylgomisin H
Tigloylgomisin H 显着诱导 Hepa1c1c7 小鼠肝癌细胞中醌还原酶 (QR) 活性。
021-51111890
购物车()
sales@molnova.cn

